Mechanically, CEH activated TLR4 and MYD88 innate immune signaling, which is advantageous for the activation of the host's innate immunity, for a balanced intestinal environment as well as to exert a chemotherapeutic response to esophageal cancer. Here, MYD88 is linked to esophageal cancer.